CD34 is a transmembrane phosphoglycoprotein, first identified on hematopoietic stem and
progenitor cells. Clinically, it is associated with the selection and enrichment of …

The lack of a functional vascular supply has, to a large extent, hampered the whole range of
clinical applications of 'successful'laboratory‐based bone tissue engineering strategies. To …

Nearly every bone in the body is invested in periosteum. The periosteum is in some ways
poorly understood and has been a subject of controversy and debate. This tissue has a …

Tissue engineering is a newly emerging biomedical technology, which aids and increases
the repair and regeneration of deficient and injured tissues. It employs the principles from …

The enhancement of bone regeneration with biological agents including osteogenic growth
factors and mesenchymal stem cells (MSCs) is becoming a clinical reality. Many exciting …

BACKGROUND Endometriosis is a complex disease with a multifactorial pathogenesis,
which is crucially dependent on the development of new blood vessels. Based on the …

Objectives To describe the biological characteristics of exosomes and to summarize the
current status of stem cell‐derived exosomes on fracture healing. Meanwhile, future …

The complexity of fracture repair makes it an ideal process for studying the interplay
between the molecular, cellular, tissue, and organ level events involved in tissue …

Background—Understanding the mechanisms of repair and regeneration of the kidney after
injury is of great interest because there are currently no therapies that promote repair, and …

The ability to exploit angiogenesis and vascularization as a therapeutic strategy will be of
enormous benefit to a wide range of medical and tissue-engineering applications …